NLRP3 and cryopyrin-associated periodic syndrome: In summary, our research provided functional results to assist diagnosis of patients with CAPS, a deeper understanding of the activation mechanisms of NLRP3 and a basis for categorizing patients for the potential use of targeted treatments in the future.